Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
“Global specimen validity testing market is projected to grow at 6.3% during the forecast period”
The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.)
“Specimen validity testing services are expected to grow at the highest CAGR during the forecast period”
The specimen validity testing market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period; growth in this segment is attributed to the growing implementation of workplace drug testing in several countries, increasing number of drug screening tests, and the growing number of drug screening laboratories across the globe.
“By type, laboratory testing is expected to dominate the market during the forecast period”
The specimen validity testing market is segmented into laboratory testing and rapid/POC testing. The laboratory testing segment is expected to dominate the market during the forecast period. The accuracy of test results and cost-effectiveness of laboratory testing are other key factors driving the demand for this segment.
“Asia Pacific to witness high growth during the forecast period”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. The high growth in the APAC regional segment is attributed to the developing healthcare infrastructure, rising adoption of stringent regulatory guidelines for drug testing, increase in the number of illicit drug users, and strategic expansion of key market players in the region.
The primary interviews conducted for this report can be categorized as follows:
The report provides an overview of the specimen validity testing market. It aims at estimating the market size and growth potential of this market across different segments such as product and service, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the specimen validity testing market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.)
“Specimen validity testing services are expected to grow at the highest CAGR during the forecast period”
The specimen validity testing market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period; growth in this segment is attributed to the growing implementation of workplace drug testing in several countries, increasing number of drug screening tests, and the growing number of drug screening laboratories across the globe.
“By type, laboratory testing is expected to dominate the market during the forecast period”
The specimen validity testing market is segmented into laboratory testing and rapid/POC testing. The laboratory testing segment is expected to dominate the market during the forecast period. The accuracy of test results and cost-effectiveness of laboratory testing are other key factors driving the demand for this segment.
“Asia Pacific to witness high growth during the forecast period”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. The high growth in the APAC regional segment is attributed to the developing healthcare infrastructure, rising adoption of stringent regulatory guidelines for drug testing, increase in the number of illicit drug users, and strategic expansion of key market players in the region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 24%; Tier 2 - 32%; Tier 3 - 44%.
- By Designation: C-level- 26%; D-level- 30%; others--44%.
- By Region: North America-48%; Europe-37%; Asia Pacific-10%; RoW-5%.
- Alere (Subsidiary of Abbott Laboratories) (US)
- Thermo Fisher (US)
- Scitek (US)
- LabCorp (US)
- Quest Diagnostics (US)
- Alfa Scientific Designs (US)
- American Bio Medica Corporation (US)
- Express Diagnostics (US)
- ACM Global Laboratories (US)
- Clinical Reference Laboratory (CRL)
- Premier Biotech (US)
The report provides an overview of the specimen validity testing market. It aims at estimating the market size and growth potential of this market across different segments such as product and service, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the specimen validity testing market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 PRIMARY SOURCES
2.3.2 KEY INDUSTRY INSIGHTS
2.4 MARKET ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SPECIMEN VALIDITY TESTING MARKET OVERVIEW
4.2 SPECIMEN VALIDITY TESTING MARKET, BY TYPE (2018 VS. 2023)
4.3 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE (2018 VS. 2023)
4.4 GEOGRAPHIC ANALYSIS: EUROPEAN SPECIMEN VALIDITY TESTING MARKET, BY END USER AND REGION (2018)
4.5 GEOGRAPHIC SNAPSHOT: SPECIMEN VALIDITY TESTING MARKET (2018–2023)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the drug screening market
5.2.1.2 Increase in workplace drug testing
5.2.2 RESTRAINTS
5.2.2.1 Emergence of alternative drug screening tests
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rapid/Point-of-care specimen validity testing
5.2.4 MARKET TRENDS
5.2.4.1 Market consolidation
5.2.4.2 Regulatory approvals for rapid testing products
6 SPECIMEN VALIDITY TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 REAGENTS, CALIBRATORS, AND CONTROLS
6.2.2 ASSAY KITS
6.2.3 DISPOSABLES
6.3 SERVICES
7 SPECIMEN VALIDITY TESTING MARKET, BY TYPE
7.1 INTRODUCTION
7.2 LABORATORY TESTING
7.3 RAPID/POC TESTING
8 SPECIMEN VALIDITY TESTING MARKET, BY END USER
8.1 INTRODUCTION
8.2 WORKPLACES
8.3 DRUG SCREENING LABORATORIES
8.4 CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES
8.5 PAIN MANAGEMENT CENTERS
8.6 DRUG REHABILITATION CENTERS
8.7 OTHER END USERS
9 SPECIMEN VALIDITY TESTING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 REST OF EUROPE (ROE)
9.4 ASIA PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET RANKING ANALYSIS, BY KEY PLAYER
10.3 COMPETITIVE SCENARIO
10.3.1 PRODUCT LAUNCHES AND APPROVALS
10.3.2 ACQUISITIONS
10.3.3 PARTNERSHIP, AGREEMENTS, AND COLLABORATION
10.3.4 EXPANSIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ALERE (SUBSIDIARY OF ABBOTT LABORATORIES)
11.2 THERMO FISHER SCIENTIFIC
11.3 LABCORP
11.4 QUEST DIAGNOSTICS
11.5 AMERICAN BIO MEDICA CORPORATION (ABMC)
11.6 SCITECK
11.7 PREMIER BIOTECH
11.8 ALFA SCIENTIFIC DESIGNS
11.9 ACM GLOBAL LABORATORIES
11.10 EXPRESS DIAGNOSTIC INTERNATIONAL
11.11 CLINICAL REFERENCE LABORATORY
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 PRIMARY SOURCES
2.3.2 KEY INDUSTRY INSIGHTS
2.4 MARKET ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SPECIMEN VALIDITY TESTING MARKET OVERVIEW
4.2 SPECIMEN VALIDITY TESTING MARKET, BY TYPE (2018 VS. 2023)
4.3 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE (2018 VS. 2023)
4.4 GEOGRAPHIC ANALYSIS: EUROPEAN SPECIMEN VALIDITY TESTING MARKET, BY END USER AND REGION (2018)
4.5 GEOGRAPHIC SNAPSHOT: SPECIMEN VALIDITY TESTING MARKET (2018–2023)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the drug screening market
5.2.1.2 Increase in workplace drug testing
5.2.2 RESTRAINTS
5.2.2.1 Emergence of alternative drug screening tests
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rapid/Point-of-care specimen validity testing
5.2.4 MARKET TRENDS
5.2.4.1 Market consolidation
5.2.4.2 Regulatory approvals for rapid testing products
6 SPECIMEN VALIDITY TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 REAGENTS, CALIBRATORS, AND CONTROLS
6.2.2 ASSAY KITS
6.2.3 DISPOSABLES
6.3 SERVICES
7 SPECIMEN VALIDITY TESTING MARKET, BY TYPE
7.1 INTRODUCTION
7.2 LABORATORY TESTING
7.3 RAPID/POC TESTING
8 SPECIMEN VALIDITY TESTING MARKET, BY END USER
8.1 INTRODUCTION
8.2 WORKPLACES
8.3 DRUG SCREENING LABORATORIES
8.4 CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES
8.5 PAIN MANAGEMENT CENTERS
8.6 DRUG REHABILITATION CENTERS
8.7 OTHER END USERS
9 SPECIMEN VALIDITY TESTING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 REST OF EUROPE (ROE)
9.4 ASIA PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET RANKING ANALYSIS, BY KEY PLAYER
10.3 COMPETITIVE SCENARIO
10.3.1 PRODUCT LAUNCHES AND APPROVALS
10.3.2 ACQUISITIONS
10.3.3 PARTNERSHIP, AGREEMENTS, AND COLLABORATION
10.3.4 EXPANSIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ALERE (SUBSIDIARY OF ABBOTT LABORATORIES)
11.2 THERMO FISHER SCIENTIFIC
11.3 LABCORP
11.4 QUEST DIAGNOSTICS
11.5 AMERICAN BIO MEDICA CORPORATION (ABMC)
11.6 SCITECK
11.7 PREMIER BIOTECH
11.8 ALFA SCIENTIFIC DESIGNS
11.9 ACM GLOBAL LABORATORIES
11.10 EXPRESS DIAGNOSTIC INTERNATIONAL
11.11 CLINICAL REFERENCE LABORATORY
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 RECENT PRODUCT LAUNCHES (2015–2017)
Table 2 RECENT ACQUISITIONS (2017)
Table 3 RECENT FDA APPROVALS FOR RAPID TESTING PRODUCTS (2017–2018)
Table 4 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 5 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 6 SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY REGION, 2016–2023 (USD MILLION)
Table 7 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY REGION, 2016–2023 (USD MILLION)
Table 10 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 12 SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY REGION, 2016–2023 (USD MILLION)
Table 13 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 14 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 SPECIMEN VALIDITY TESTING SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 16 NORTH AMERICA: SPECIMEN VALIDITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 EUROPE: SPECIMEN VALIDITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 18 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 19 LABORATORY TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 20 NORTH AMERICA: LABORATORY TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 21 EUROPE: LABORATORY TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 22 RAPID/POC TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 23 NORTH AMERICA: RAPID/POC TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 24 EUROPE: RAPID/POC TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 25 SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 26 SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY REGION, 2016–2023 (USD MILLION)
Table 27 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
Table 30 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 32 SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY REGION, 2016–2023 (USD MILLION)
Table 33 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 35 SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 37 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 38 SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 40 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 41 SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
Table 42 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 43 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 44 SPECIMEN VALIDITY TESTING MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 45 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 46 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 47 NORTH AMERICA: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 48 NORTH AMERICA: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 49 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 50 US: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 51 US: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 52 US: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 53 US: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 54 CANADA: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 55 CANADA: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 56 CANADA: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 57 CANADA: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 58 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 59 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 60 EUROPE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 61 EUROPE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 GERMANY: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 64 GERMANY: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 GERMANY: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 GERMANY: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 67 FRANCE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 FRANCE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 69 FRANCE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 70 FRANCE: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 71 UK: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 UK: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 UK: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 74 UK: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 75 ROE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 ROE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 77 ROE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 78 ROE: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 79 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 ASIA PACIFIC: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 ASIA PACIFIC: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 83 ROW: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 84 ROW: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 ROW: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 86 ROW: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 87 SPECIMEN VALIDITY TESTING MARKET RANKING (2017), BY KEY PLAYER
Table 88 PRODUCT LAUNCHES AND APPROVALS
Table 89 MERGERS AND ACQUISITIONS
Table 90 PARTNERSHIP, AGREEMENTS, AND COLLABORATION
Table 91 EXPANSIONS
Table 1 RECENT PRODUCT LAUNCHES (2015–2017)
Table 2 RECENT ACQUISITIONS (2017)
Table 3 RECENT FDA APPROVALS FOR RAPID TESTING PRODUCTS (2017–2018)
Table 4 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 5 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 6 SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY REGION, 2016–2023 (USD MILLION)
Table 7 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR REAGENTS, CALIBRATORS, AND CONTROLS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY REGION, 2016–2023 (USD MILLION)
Table 10 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR ASSAY KITS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 12 SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY REGION, 2016–2023 (USD MILLION)
Table 13 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 14 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 SPECIMEN VALIDITY TESTING SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 16 NORTH AMERICA: SPECIMEN VALIDITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 EUROPE: SPECIMEN VALIDITY TESTING SERVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 18 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016-2023 (USD MILLION)
Table 19 LABORATORY TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 20 NORTH AMERICA: LABORATORY TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 21 EUROPE: LABORATORY TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 22 RAPID/POC TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
Table 23 NORTH AMERICA: RAPID/POC TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 24 EUROPE: RAPID/POC TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
Table 25 SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 26 SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY REGION, 2016–2023 (USD MILLION)
Table 27 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR WORKPLACES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
Table 30 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DRUG SCREENING LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 32 SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY REGION, 2016–2023 (USD MILLION)
Table 33 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 35 SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 37 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 38 SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 40 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR DRUG REHABILITATION CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 41 SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
Table 42 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 43 EUROPE: SPECIMEN VALIDITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 44 SPECIMEN VALIDITY TESTING MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 45 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 46 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 47 NORTH AMERICA: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 48 NORTH AMERICA: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 49 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 50 US: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 51 US: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 52 US: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 53 US: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 54 CANADA: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 55 CANADA: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 56 CANADA: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 57 CANADA: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 58 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 59 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 60 EUROPE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 61 EUROPE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 EUROPE: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 GERMANY: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 64 GERMANY: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 GERMANY: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 GERMANY: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 67 FRANCE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 FRANCE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 69 FRANCE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 70 FRANCE: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 71 UK: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 UK: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 UK: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 74 UK: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 75 ROE: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 ROE: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 77 ROE: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 78 ROE: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 79 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 ASIA PACIFIC: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 ASIA PACIFIC: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 83 ROW: SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 84 ROW: SPECIMEN VALIDITY TESTING PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 ROW: SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 86 ROW: SPECIMEN VALIDITY TESTING MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 87 SPECIMEN VALIDITY TESTING MARKET RANKING (2017), BY KEY PLAYER
Table 88 PRODUCT LAUNCHES AND APPROVALS
Table 89 MERGERS AND ACQUISITIONS
Table 90 PARTNERSHIP, AGREEMENTS, AND COLLABORATION
Table 91 EXPANSIONS
LIST OF FIGURES
Figure 1 SPECIMEN VALIDITY TESTING MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
Figure 4 BOTTOM-UP APPROACH
Figure 5 TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 SPECIMEN VALIDITY TESTING MARKET SNAPSHOT: LABORATORY TESTING VS RAPID/POC TESTING (2018 VS. 2023)
Figure 8 SPECIMEN VALIDITY TESTING SERVICES TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 9 REAGENTS, CALIBRATORS, & CONTROLS TO DOMINATE THE SPECIMEN VALIDITY TESTING PRODUCTS MARKET IN 2018
Figure 10 WORKPLACES SEGMENT TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET IN 2018
Figure 11 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 12 INCREASE IN WORKPLACE DRUG TESTING IS DRIVING THE GROWTH OF THE SPECIMEN VALIDITY TESTING MARKET
Figure 13 LABORATORY TESTING SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2023
Figure 14 REAGENTS, CALIBRATORS, AND CONTROLS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD (2018–2023)
Figure 15 WORKPLACES SEGMENT TO DOMINATE THE EUROPEAN SPECIMEN VALIDITY TESTING MARKET IN 2018
Figure 16 SPECIMEN VALIDITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS
Figure 17 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
Figure 18 REAGENTS, CALIBRATORS, AND CONTROLS TO DOMINATE THE SPECIMEN VALIDITY TESTING PRODUCTS MARKET IN 2018
Figure 19 RAPID/POC TESTING SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 20 WORKPLACE DRUG TESTING TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET DURING THE FORECAST PERIOD
Figure 21 NORTH AMERICA TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET DURING THE FORECAST PERIOD
Figure 22 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 23 EUROPE: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 24 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 25 REST OF THE WORLD: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 26 KEY DEVELOPMENTS IN THE SPECIMEN VALIDITY MARKET BETWEEN 2015 AND 2018
Figure 27 MARKET EVOLUTION FRAMEWORK
Figure 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
Figure 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Figure 30 LABCORP: COMPANY SNAPSHOT (2017)
Figure 31 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2017)
Figure 32 AMERICAN BIO MEDICA CORPORATION (ABMC): COMPANY SNAPSHOT (2017)
Figure 1 SPECIMEN VALIDITY TESTING MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
Figure 4 BOTTOM-UP APPROACH
Figure 5 TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 SPECIMEN VALIDITY TESTING MARKET SNAPSHOT: LABORATORY TESTING VS RAPID/POC TESTING (2018 VS. 2023)
Figure 8 SPECIMEN VALIDITY TESTING SERVICES TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 9 REAGENTS, CALIBRATORS, & CONTROLS TO DOMINATE THE SPECIMEN VALIDITY TESTING PRODUCTS MARKET IN 2018
Figure 10 WORKPLACES SEGMENT TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET IN 2018
Figure 11 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 12 INCREASE IN WORKPLACE DRUG TESTING IS DRIVING THE GROWTH OF THE SPECIMEN VALIDITY TESTING MARKET
Figure 13 LABORATORY TESTING SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2023
Figure 14 REAGENTS, CALIBRATORS, AND CONTROLS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD (2018–2023)
Figure 15 WORKPLACES SEGMENT TO DOMINATE THE EUROPEAN SPECIMEN VALIDITY TESTING MARKET IN 2018
Figure 16 SPECIMEN VALIDITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS
Figure 17 SPECIMEN VALIDITY TESTING MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
Figure 18 REAGENTS, CALIBRATORS, AND CONTROLS TO DOMINATE THE SPECIMEN VALIDITY TESTING PRODUCTS MARKET IN 2018
Figure 19 RAPID/POC TESTING SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 20 WORKPLACE DRUG TESTING TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET DURING THE FORECAST PERIOD
Figure 21 NORTH AMERICA TO DOMINATE THE SPECIMEN VALIDITY TESTING MARKET DURING THE FORECAST PERIOD
Figure 22 NORTH AMERICA: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 23 EUROPE: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 24 ASIA PACIFIC: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 25 REST OF THE WORLD: SPECIMEN VALIDITY TESTING MARKET SNAPSHOT
Figure 26 KEY DEVELOPMENTS IN THE SPECIMEN VALIDITY MARKET BETWEEN 2015 AND 2018
Figure 27 MARKET EVOLUTION FRAMEWORK
Figure 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
Figure 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Figure 30 LABCORP: COMPANY SNAPSHOT (2017)
Figure 31 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2017)
Figure 32 AMERICAN BIO MEDICA CORPORATION (ABMC): COMPANY SNAPSHOT (2017)
